A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body (clinicaltrials.gov) - Jun 17, 2026 - P1 | N=63 | Not yet recruiting | Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
First-in-human • New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Scleroderma • Systemic Lupus Erythematosus • Systemic Sclerosis
|